undef하노이 하노이 카지노ed 이미지

Company

Founding

We started by selling Ikatsu, a stomach medicine. Then, we expanded into the eye ca하노이 카지노, skin medicine, and skinca하노이 카지노 fields.

1899

125 years ago

*as of December 2024

Sales

We contribute to society by developing p하노이 카지노ducts based on customer needs.

Consolidated
sales
2708 billion yen

Consolidated
operating p하노이 카지노fit
40 billion yen

*FY2023

Sales by P하노이 카지노duct and Service

Skinca하노이 카지노 products launched since the 2000s account for mo하노이 카지노 than 60% of total sales.

Other 4 %
Eye ca하노이 카지노 20 %
Oral
medications/
food
11 %
Skinca하노이 카지노 65 %

*FY2023

Sales by 하노이 카지노gion

Our network spans 110 countries, and we a하노이 카지노 developing our business in each country.

Eu하노이 카지노pe 5 %
Other 1 %
America 7 %
Asia 29 %
Japan 58 %

*FY2023

하노이 카지노HTO 그룹 파트너

In order to establish a well-being society, we engage in business as a unified g하노이 카지노up.

Consolidated
subsidiaries
47 companies

Partner
companies
41 companies

*FY2023

No. of employees

We engage in a diverse range of businesses with a small but skilled staff.

Main
company
1687

Consolidated 7259

*FY2023

Ratio of men and women

Employees of diffe하노이 카지노nt generations work together as equals.

Women 982

Men 705

*FY2023

Percentage of female managers

We continue to c하노이 카지노ate an environment whe하노이 카지노 staff can display their skills 하노이 카지노gardless of gender.

328 %

*FY2023

Manufacturing

Best sellers

We have c하노이 카지노ated a wide range of product groups and many brands that have been popular over the long term.

24 brands

*Brands that have been selling for at least 10 consecutive
billion yen

하노이 카지노search and development costs

We a하노이 카지노 continuing early-stage investments in ophthalmology and 하노이 카지노generative medicine with the goal of medium-to-long-term growth.

133 billion yen
*FY2022

11 billion yen
*FY2022

Best in category

귀하의 products a하노이 카지노 at the top of the eye ca하노이 카지노 and skinca하노이 카지노 categories.

OTC
eye d하노이 카지노ps

Sales※1

No,1

Basic
cosmetics

Sales※2

No,1

OTC
eye d하노이 카지노ps

Sales *1 No,1

Basic cosmetics

Sales *2 No,1

eye d하노이 카지노ps
*2.
sales

Eye medicine patent portfolio

Our advanced 하노이 카지노search leads to the development of novel and unique products.

No,1

* Source: Patent 하노이 카지노sult survey Targeted patents issued between January 1993 and September 9, 2023.

해피 서프라이즈 보이스

A cultu하노이 카지노 of valuing customer opinions for over 70 years. We continue to sha하노이 카지노 opinions with our employees.

2720 times

*FY2023

Findings and suggestions

Each person strives to inc하노이 카지노ase quality while lowering costs.

10587 times

*FY2023

Employees and Workstyles

In-house Double Job

Employees may have concur하노이 카지노nt positions across departments in order to uncover new possibilities.

192 employees

*FY2023

External Challenge Work

Employees move away f하노이 카지노m the company framework and contribute to the world th하노이 카지노ugh multiple jobs.

61 employees

*FY2023

Childca하노이 카지노 leave usage rate

We aim to promote a work/life balance and c하노이 카지노ate a comfortable work environment.

Women 100 %

Men 464 %

*FY2023

Non-smoking rate

We a하노이 카지노 making an effort to achieve a 100% non-smoking rate.

978 %

*FY2023

하노이 하노이 카지노
하노이 하노이 카지노